株探米国株
日本語 英語
エドガーで原本を確認する
false 0001374328 0001374328 2025-03-13 2025-03-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): March 13, 2025
 
Commission File Number: 000-52369
 
FitLife Brands, Inc.
(Exact name of registrant as specified in its charter.)
 
Nevada
20-3464383
(State or other jurisdiction of incorporation
or organization)
(IRS Employer Identification No.)
 
5214 S. 136th Street, Omaha, Nebraska 68137
(Address of principal executive offices)
 
402-884-1894
(Registrant's Telephone number)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock, par value $0.01 per share
FTLF
Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


 
Item 2.02     Results of Operations and Financial Condition.
 
On March 13, 2025, FitLife Brands, Inc. (the “Company”) issued a press release announcing the Company’s preliminary financial results for the fiscal year ended December 31, 2024. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
 
Item 7.01     Regulation FD Disclosure
 
On March 13, 2025, the Company began utilizing a new corporate presentation for business purposes. A copy of the corporate presentation is attached to this Current Report on Form 8-K as Exhibit 99.2.
 
Disclaimer.
 
The information furnished pursuant to Item 2.02 and 7.01, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by referenced.
 
Item 9.01     Financial Statements and Exhibits.
 
(d) Exhibits Index
 
Exhibit
No.
 
Description
99.1
 
99.2
 
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 


 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
FitLife Brands, Inc.
     
Date: March 13, 2025
By:
/s/ Dayton Judd
   
Dayton Judd
   
Chief Executive Officer
 
 
EX-99.1 2 ex_789398.htm EXHIBIT 99.1 ex_789398.htm
 

Exhibit 99.1

 

fitlifelogo.jpg
 

FitLife Brands Announces its Participation at the 37th Annual Roth

Conference and Provides Financial and Operational Update

 

OMAHA, NE – March 13, 2025 – FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the 37th Annual Roth Conference on Monday and Tuesday, March 17-18, 2025. Investors who are interested in meeting with FitLife management should submit their requests through their Roth representative.

 

In conjunction with its participation in the conference, the Company has prepared an updated investor presentation which will be filed with the Securities and Exchange Commission on Form 8-K in advance of the conference.

 

The Company plans to report its financial performance for the fourth quarter and full year of 2024 with the Securities and Exchange Commission on Form 10-K on March 27, 2025. However, in order to facilitate upcoming investor discussions, the Company is providing the following financial and operational update regarding the Company’s recent performance:

 

 

Net revenue for the full year 2024 is anticipated to be between $64-65 million, an increase of 21-23% compared to 2023.

     
 

Adjusted EBITDA for the full year 2024 is anticipated to be between $14.0-14.2 million, an increase of 38-40% compared to 2023.

     
 

Net income for the full year 2024 is anticipated to be between $8.9-9.1 million, an increase of 68-72% compared to 2023.

     
 

As of December 31st, 2024, the Company had $13.1 million outstanding on its term loan and no balance outstanding on its revolver.

     
 

As of December 31st, 2024, the Company had $4.5 million of cash.

     
 

Shares outstanding as of March 12, 2025 were 9,218,528.

 

1

 

About FitLife Brands

 

FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers. FitLife markets more than 250 different products primarily online, but also through domestic and international GNC® franchise locations as well as through various other retail locations. FitLife is headquartered in Omaha, Nebraska. For more information, please visit our website at www.fitlifebrands.com.

 

Forward-Looking Statements

 

Statements in this release that are forward-looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to, the ability of the Company to continue to grow revenue, and the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in the Company's filings with the Securities and Exchange Commission including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

 

Non-GAAP Financial Measures 

 

This press release contains certain financial measures defined as “non-GAAP financial measures” by the SEC, including non-GAAP adjusted EBITDA. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. 

 

As presented herein, non-GAAP EBITDA excludes interest, foreign exchange gains and losses, income taxes, and depreciation and amortization. Adjusted non-GAAP EBITDA excludes, in addition to interest, foreign exchange gains and losses, taxes, depreciation and amortization, equity-based compensation, M&A/integration activities, and non-recurring gains or losses. The Company believes the non-GAAP measures provide useful information to both management and investors by excluding certain expenses and other items that may not be indicative of its core operating results and business outlook. The Company believes that the inclusion of non-GAAP measures in the financial presentation herein allows investors to compare the Company’s financial results with the Company’s historical financial results and is an important measure of the Company’s comparative financial performance. 

 

2
EX-99.2 3 ex_789399.htm EXHIBIT 99.2 Image Exhibit

 Exhibit 99.2

slide01.jpg


slide02.jpg

 



slide03.jpg

 



slide04.jpg

 



slide05.jpg

 



slide06.jpg

 



slide07.jpg

 



slide08.jpg

 



slide09.jpg

 



slide10.jpg

 



slide11.jpg

 



slide12.jpg

 



slide13.jpg

 



slide14.jpg

 



slide15.jpg

 



slide16.jpg

 



slide17.jpg

 



slide18.jpg

 



slide19.jpg

 



slide20.jpg